1 year return (CAGR)
-86.90%
Anebulo Pharmaceuticals Inc Exchange (NASDAQ, USD)
ANEB
0.33
+0.03 (+8.33%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-53.68%
5 year return (CAGR)
-45.76%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
13.26M
Price/Sales
-
Ent value
5.70M
Price/Book
1.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-35.35%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.33 |
| Daily high | 0.33 |
| Daily low | 0.33 |
| Daily Volume | 0K |
| All-time high | 8.95 |
| 1y analyst estimate | 3.00 |
| Beta | -1.83 |
| EPS (TTM) | -0.19 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 7 May 2026 |
Downside potential
Loading...
Downside potential data
| ANEB | S&P500 | |
| Current price drop from All-time high | -96.37% | -1.38% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 15 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -66.78% | -10.68% |
| Avg time to new high | 270 days | 12 days |
| Max time to new high | 1341 days | 1805 days |
News
